Related Experiment Video
Updated: Jun 23, 2026

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
A Metal-Phenolic Nanocluster Orchestrates Mito-Ca2+ Metabolic Autonomy for Tumor Ca2+ Interference Therapy
Ronglong Chen1, Jia Huang2, Yuepeng Wang3,4
1Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Abstract:
Mitochondrial Ca2+(mito-Ca2+) interference, an effective mitochondria destruction strategy in cancer treatment, suffers from precise self-protective Ca2+ metabolic autoregulation by Ca2+ channels. Direct regulation of Ca2+ channels-mediated mito-Ca2 + metabolic autonomy will overcome this obstacle for advanced Ca2+ interference therapy. Here, we engineer a novel meta-phenolic nanocluster (TCMH) by self-assembly of polyphenols encapsulating mitochondrial calcium uniporter (MCU) modulators (mitofusin 1 siRNA (siMFN1), H2S donor) and Ca2+ via metal-phenolic coordination. After cellular internalization, the acid-responsive disassembly of TCMH triggers the release of its' payloads. TCMH promotes a rapid surge in mito-Ca2+ via synergistic MCU activation by siMFN1-mediated mitochondrial fusion suppression and released H2S. Furthermore, integrating with H2S-mediated reactive oxygen species (ROS) enrichment, this Ca2+-based TCMH forms a self-amplifying ROS-Ca2 + positive feedback loop to sensitize mitochondrial apoptosis. TCMH potently benefits robust antitumor therapeutics in both oral squamous cell carcinoma orthotopic and patient-derived xenograft models. Together, a powerful MCU-mediated mito-Ca2+ metabolic autonomy modulation tactic is highlighted here to optimize precise tumor Ca2+ interference therapy.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Drugs that Stabilize Microtubules